BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 31161900)

  • 1. LINC00958 regulated miR-627-5p/YBX2 axis to facilitate cell proliferation and migration in oral squamous cell carcinoma.
    Chen F; Liu M; Yu Y; Sun Y; Li J; Hu W; Wang X; Tong D
    Cancer Biol Ther; 2019; 20(9):1270-1280. PubMed ID: 31161900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression.
    Niu X; Yang B; Liu F; Fang Q
    Biomed Pharmacother; 2020 Jan; 121():109623. PubMed ID: 31731187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA LINC00958 promotes the oral squamous cell carcinoma by sponging miR-185-5p/YWHAZ.
    Wang Z; Zhu X; Dong P; Cai J
    Life Sci; 2020 Feb; 242():116782. PubMed ID: 31442551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA LINC00958 and microRNA miR-627-5p provide candidate diagnostic biomarker and participate tumor progression in laryngeal squamous cell carcinoma: a retrospective study.
    Zhang C; Ma R
    J Physiol Pharmacol; 2023 Apr; 74(2):. PubMed ID: 37453096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
    Han L; Cheng J; Li A
    Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
    [No Abstract]   [Full Text] [Related]  

  • 6. The regulation of long non-coding RNA 00958 (LINC00958) for oral squamous cell carcinoma (OSCC) cells death through absent in melanoma 2 (AIM2) depending on microRNA-4306 and Sirtuin1 (SIRT1) in vitro.
    Jiang L; Ge W; Cui Y; Wang X
    Bioengineered; 2021 Dec; 12(1):5085-5098. PubMed ID: 34384029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8.
    Chen S; Chen JZ; Zhang JQ; Chen HX; Qiu FN; Yan ML; Tian YF; Peng CH; Shen BY; Chen YL; Wang YD
    Cancer Lett; 2019 Apr; 446():49-61. PubMed ID: 30639194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M; Wang C; Chen W; Mao C; Wang J
    DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-4282 inhibits tumor progression through down-regulation of ZBTB2 by targeting LIN28B in oral squamous cell carcinoma.
    Zhang Y; Zhang Z; Huang W; Zeng J
    J Cell Physiol; 2020 Nov; 235(11):8035-8047. PubMed ID: 31970774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA GAS5 suppresses proliferation, migration, invasion, and epithelial-mesenchymal transition in oral squamous cell carcinoma by regulating the miR-21/PTEN axis.
    Zeng B; Li Y; Jiang F; Wei C; Chen G; Zhang W; Zhao W; Yu D
    Exp Cell Res; 2019 Jan; 374(2):365-373. PubMed ID: 30576678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-155-5p promotes oral cancer progression by targeting chromatin remodeling gene ARID2.
    Wu M; Duan Q; Liu X; Zhang P; Fu Y; Zhang Z; Liu L; Cheng J; Jiang H
    Biomed Pharmacother; 2020 Feb; 122():109696. PubMed ID: 31918270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA DANCR regulates the growth and metastasis of oral squamous cell carcinoma cells via altering miR-216a-5p expression.
    Qu XH; Shi YL; Ma Y; Bao WW; Yang L; Li JC; Zhang F
    Hum Cell; 2020 Oct; 33(4):1281-1293. PubMed ID: 32860589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
    J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of transforming growth factor-beta1 by circANKS1B/miR-515-5p affects the metastatic potential and cisplatin resistance in oral squamous cell carcinoma.
    Yan J; Xu H
    Bioengineered; 2021 Dec; 12(2):12420-12430. PubMed ID: 34781814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
    Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY
    J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of miR-218-GREM1 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma: An in vivo and vitro study based on microarray data.
    Wang Y; Jiang Y; Chen L
    J Cell Mol Med; 2020 Dec; 24(23):13824-13836. PubMed ID: 33107676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA SNHG20 promotes the tumorigenesis of oral squamous cell carcinoma via targeting miR-197/LIN28 axis.
    Wu J; Zhao W; Wang Z; Xiang X; Zhang S; Liu L
    J Cell Mol Med; 2019 Jan; 23(1):680-688. PubMed ID: 30394668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QKI, a miR-200 target gene, suppresses epithelial-to-mesenchymal transition and tumor growth.
    Kim EJ; Kim JS; Lee S; Lee H; Yoon JS; Hong JH; Chun SH; Sun S; Won HS; Hong SA; Kang K; Jo JY; Choi M; Shin DH; Ahn YH; Ko YH
    Int J Cancer; 2019 Sep; 145(6):1585-1595. PubMed ID: 31026342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linc01234 promotes cell proliferation and metastasis in oral squamous cell carcinoma via miR-433/PAK4 axis.
    Liu D; Jian X; Xu P; Zhu R; Wang Y
    BMC Cancer; 2020 Feb; 20(1):107. PubMed ID: 32041570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.